Clinical Trial

Efficacy of Tofacitinib, Methotrexate Combination Therapy Versus Upadacitinib, Methotrexate Combination Therapy in Moderate to Severe Rheumatoid Arthritis

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The aim of this study is to assess the efficacy of upadacitinib, methotrexate combination therapy in comparison to tofacitinib, methotrexate combination therapy in moderate to severe RA patients. This study will guide us to treat RA patients with inadequate response to methotrexate more effectively
Trial Details
NCT Number NCT07008846
Lead Sponsor Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Conditions Moderate to Severe Rheumatoid Arthritis
Enrollment 96 participants
Start Date 2025-05-10
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-06